HCW Biologics Inc. (HCWB) Stock

Healthcare · Biotechnology · Member of Other US Stocks

HCW Biologics Inc. (HCWB) closed at USD 1.23 on 2026-10-15, a change of -94.7 % over the past year, with a market capitalization of USD 2.77M.

HCW Biologics Inc. recent closing prices

DateClose (USD)
2026-10-151.23
2026-10-141.17
2026-10-131.26
2026-10-121.48
2026-10-091.60
2026-10-081.53
2026-10-071.56

The most recent trading day is not shown. For full charts and indicators use the analysis page.

HCW Biologics Inc. key figures

Previous close
USD 1.23 (2026-10-15)
1-year change
-94.7 %
Market cap
USD 2.77M
Enterprise value
USD 8.1M
P/E ratio (trailing)
-0.06
P/E ratio (forward)
-2.26
EPS (trailing)
-19.84
EPS (forward)
-0.55
PEG ratio
n/a
Price to book
0.27
Revenue growth
1,969.7 %
Earnings growth
n/a
Dividend per share (trailing)
0.00
Short ratio
0.07
Employees
35
Analyst consensus (third-party)
buy

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About HCW Biologics Inc.

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States. Its lead products include HCW11-018b, a novel, tetra-valent T-Cell engager; HCW11-040, a multifunctional fusion molecule that is a combination of cytokines and pembrolizumab; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in clinical trial in patients with alopecia areata diseases. The company also develops HCW9201, a fusion protein designed as a reagent to use in the production of natural killer (NK) cell-based therapies; HCW9206, a fusion protein designed as a reagent to use in the production of CAR-therapies for the treatment of infectious diseases; and HCW11-006, a multi-functional immune cell stimulator. It has a license agreement with Wugen Inc. to develop cell therapy-based treatments; and a license, research and co-development agreement with WY Biotech Co., Ltd. for its preclinical molecule. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for HCW Biologics Inc. and compare it with other stocks.

Analyze HCWBAll Other US Stocks stocks

Stock-scoring.com provides this page for information only. It is not investment advice or a recommendation to buy or sell HCW Biologics Inc. shares.